Lifecore Biomedical Inc. (LFCR) Stock: Dividends & Earnings

Company Overview:

Market Cap: $0

Trailing PE: N/A

FWD PE: —

Payout Ratio (TTM): —

52-Week Range: $3.63 - $8.98

10 Year LFCR Performance Metrics:

Total Return (with DRIP): -50.7% (-6.82% CAGR)

Total Return (no DRIP): -50.7% (-6.82% CAGR)

Share Price: -50.9% (-6.87% CAGR)

Yield on Cost (with DRIP): —

Total Invested: $10,000

Total Value (with DRIP): $4,933

Total Return $ (with DRIP): -$5,067

LFCR Total Return

1M 3M 6M YTD 1Y 3Y 5Y 10Y

LFCR Price Chart

1M 3M 6M YTD 1Y 3Y 5Y 10Y All

Unlock All Reports & Research Dividend Stocks like a BOSS!

Save 25% with annual plan (3 Months Free)

PRO

$171 ($14.25/mo) $102.60/yr ($8.55/mo)

7-day free trial

Unlimited Portfolio Tracker
Portfolio - Lots/Sales/Dividends
Portfolio Auto-DRIP
Buy/Sell Signals Dashboard
Stock Fundamentals
Compare Stocks Side-by-Side
Revenue & EPS Estimates
DCF Valuation Modeling

Try it free for 7 days

You save $125.40 (55%)

Projected Future Returns & Dividends for LFCR

Based on past 10-year performance, here are LFCR growth metrics:

Share price CAGR of -6.87%
Dividend CAGR of +0%

Using LFCR CAGR metrics, we can estimate that your initial $10000 investment, over the next 10 years, should grow as follows:

	LFCR (DRIP)	LFCR - No DRIP
Current Price	$6.58	$6.58
Start Shares	1,519.76	1,519.76
Start Value	$10,000	$10,000

After 10 years:
Final Share Count	1,519.76	1,519.76
Dividends Payment	$0.00	$0.00
Annual Dividends	$0	$0
Yield on cost	0.00%	0.00%
Share Price	$3.23	$6.58
Total Dividends	$0	$0
Final Value	$4,907	$10,000

Estimated Future Value + Dividends - LFCR

NOTE: Above numbers are our estimate based on LFCR's Dividend and Price CAGR over past 10 years. These numbers should only be considered as "potential future returns"! DRIP assumes reinvesting dividends; No-DRIP assumes collecting dividends as cash.

We cannot guarantee that your actual returns will meet these estimates.

Get the best Dividend Stock Research Tools:

Save 25% with annual plan (3 Months Free)

PRO

$171 ($14.25/mo) $102.60/yr ($8.55/mo)

7-day free trial

Unlimited Portfolio Tracker
Portfolio - Lots/Sales/Dividends
Portfolio Auto-DRIP
Buy/Sell Signals Dashboard
Stock Fundamentals
Compare Stocks Side-by-Side
Revenue & EPS Estimates
DCF Valuation Modeling

Try it free for 7 days

You save $125.40 (55%)

Company Info

Lifecore Biomedical Inc. (LFCR) had its IPO on , and is traded on NASDAQ stock exchange.

Lifecore Biomedical Inc. is a contract development and manufacturing organization focused on sterile injectable pharmaceuticals and medical device products. The company provides development, aseptic fill-finish, and commercial manufacturing services for products packaged in syringes, vials, and cartridges. It also produces pharmaceutical-grade hyaluronic acid, a biomaterial used in a range of medical applications, including ophthalmic and orthopedic products. Lifecore Biomedical Inc. serves pharmaceutical and medical device customers that need regulated manufacturing expertise, formulation support, and process scale-up capabilities. Headquartered in Chaska, Minnesota, the company operates in the biopharmaceutical manufacturing and biomaterials markets, where it plays a specialized role in supporting complex injectable therapies and related healthcare products.

LFCR website: https://www.lifecore.com